Tianyin Pharmaceutical Co., Inc. to Report 2008 Fiscal Fourth Quarter and Year End Results on September 29, 2008

Wednesday, September 24, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

CHENGDU, China, Sept. 23 TianyinPharmaceutical, Co., Inc., (OTC Bulletin Board: TYNP), a manufacturer andsupplier of modernized traditional Chinese medicine ("TCM") based in Chengdu,China, today announced that management will hold a conference call at 9:00 A.M.EDT on Monday, September 29, 2008, to discuss its 2008 fiscal fourth quarterand year end results. Financial results will be released that day before themarket opens.

Interested parties may access the call by dialing 800-762-8795 from withinthe United States, or 480-629-9031 if calling internationally. The conferenceID is 3924338. It is advisable to dial in approximately 5-10 minutes prior tothe start of the call. A replay will be available through October 13, 2008and can be accessed by dialing 800-406-7325 (U.S.), 303-590-3030 (Int'l),passcode 3924338.

This call is being web cast by ViaVid Broadcasting and can be accessed atViaVid's website at http://viavid.net or at the following link:http://viavid.net/dce.aspx?sid=00005691 . The web cast can be accessed untilOctober 29, 2008. To access the web cast, you will need to have the WindowsMedia Player on your desktop. For the free download of the Media Playerplease visit:http://microsoft.com/windows/windowsmedia/en/download/default.asp .

About Tianyin Pharmaceuticals

Tianyin is a manufacturer and supplier of modernized Traditional ChineseMedicine ("TCM") in China. It was established in 1994 and acquired by thecurrent management team in August 2003. It has a comprehensive productportfolio of 33 modernized TCMs and 4 generic western medicines in the market,22 of which are listed in the highly selective National Medicine Catalog ofthe National Medical Insurance Program. Tianyin owns and operates two GMPmanufacturing facilities and an R&D platform supported by leading Chineseacademic institutions. The Company has a pipeline of 48 pharmaceuticalproducts pending approval. Tianyin has an extensive nationwide distributionnetwork throughout China with a sales force of 720 salespeople. Tianyin isheadquartered in Chengdu, Sichuan Province with two manufacturing facilitiesand a total of 1,384 employees. Tianyin achieved revenue of $20.4 million andnet income of $3.95 million in FY2007 ending June 30, 2007. For moreinformation about Tianyin Pharmaceuticals, please visithttp://tianyinpharma.com .

Safe Harbor Statement

The Statements which are not historical facts contained in this pressrelease are forward-looking statements that involve certain risks anduncertainties including but not limited to risks associated with theuncertainty of future financial results, additional financing requirements,development of new products, government approval processes, the impact ofcompetitive products or pricing, technological changes, the effect of economicconditions and other uncertainties detailed in the Company's filings with theSecurities and Exchange Commission.For more information, please contact: For the Company: Allen Tang, Ph.D., MBA, Assistant to the CEO China Tel: +86-158-2122-5642 Email: Allen.y.tang@gmail.com Investors: HC International, Inc. Alan Sheinwald US Tel: +1-914-669-0222 Email: Alan.Sheinwald@hcinternational.net

SOURCE Tianyin Pharmaceutical, Co., Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store